| [1] |
GARCIA-TSAO G, ABRALDES JG, BERZIGOTTI A, et al. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases[J]. Hepatology, 2017, 65(1): 310-335.
|
| [2] |
TsochatzisEA, BOSCH J, Burroughs AK. Liver cirrhosis[J]. Lancet 2014, 383(9930): 1749-1761.
|
| [3] |
Boyer TD, Haskal ZJ, American Association for the Study of Liver Diseases. The Role of Transjugular Intrahepatic Portosystemic Shunt(TIPS) in the Management of Portal Hypertension: update 2009[J]. Hepatology, 2010, 51(1): 306.
|
| [4] |
RichterI GM, Palmaz JC, Noldge G, et al. The transjugular intrahepatic portosystemic stent-shunt. A new nonsurgical percutaneous method[J]. Radiologe, 1989, 29(8): 406-411.
|
| [5] |
中华医学会消化病学分会消化介入学组. 经颈静脉肝内门体静脉分流术治疗肝硬化门静脉高压共识意见[J]. 临床肝胆病杂志, 2014, 30(3): 210-3.
|
| [6] |
陈辉, 吕勇, 王秋和, 等. 经颈静脉肝内门体分流术专家共识[J]. 临床肝胆病杂志, 2017, 33(7): 1218-28.
|
| [7] |
曹家伟, 丁鹏绪, 段峰, 等. 中国门静脉高压经颈静脉肝内门体分流术临床实践指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2694-9.
|
| [8] |
中华医学会消化病学分会微创介入协作组. 经颈静脉肝内门体静脉分流术治疗门静脉高压专家共识(2022年版)[J]. 中华肝脏病杂志, 2022,(12): 1349-64.
|
| [9] |
DE Franchis R, Baveno VIF. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension[J]. J Hepatol, 2015, 63(3): 743-752.
|
| [10] |
Burroughs AK, Vangeli M. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis[J]. Scand J Gastroenterol, 2002, 37(3): 249-252.
|
| [11] |
Rossle M, Gerbes AL. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update[J]. Gut, 2010, 59(7): 988-1000.
|
| [12] |
Spencer EB, Cohen DT, Darcy MD. Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax[J]. J Vasc Interv Radiol, 2002, 13(4): 385-390.
|
| [13] |
Brensing KA, Textor J, Perz J, et al. Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study[J]. Gut, 2000, 47(2): 288-295.
|
| [14] |
Seijo S, Plessier A, Hoekstra J, et al. Good long-term outcome of Budd-Chiari syndrome with a step-wise management[J]. Hepatology, 2013, 57(5): 1962-1968.
|
| [15] |
Van Ha TG, Hodge J, Funaki B, et al. Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis[J]. Cardiovasc Intervent Radiol, 2006, 29(5): 785-790.
|
| [16] |
Trebicka J, Gu W, Ibanez-Samaniego L, et al. Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS[J]. J Hepatol, 2020, 73(5): 1082-1091.
|
| [17] |
Nicoara-Farcau O, Han G, Rudler M, et al. Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data[J]. Gastroenterology, 2021, 160(1): 193-205 e10.
|
| [18] |
Bureau C, Thabut D, Oberti F, et al. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites[J]. Gastroenterology, 2017, 152(1): 157-163.
|
| [19] |
Abralbes JG, Tarantino I, Turnes J, et al. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis[J]. Hepatology, 2003, 37(4): 902-908.
|
| [20] |
Zhang M, Wang G, Zhao L, et al. Second prophylaxis of variceal bleeding in cirrhotic patients with a high HVPG[J]. Scand J Gastroenterol, 2016, 51(12): 1502-1506.
|
| [21] |
Lv Y, Qi X, He C, et al. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial[J]. Gut, 2018, 67(12): 2156-2168.
|
| [22] |
Tripathi D, Stanley AJ, Hayes PC, et al. Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension[J]. Gut, 2020, 69(7): 1173-1192.
|
| [23] |
Anand R, AliS E, Raissi D, et al. Duodenal variceal bleeding with large spontaneous portosystemic shunt treated with transjugular intrahepatic portosystemic shunt and embolization: A case report[J]. World J Radiol, 2019, 11(8): 110-115.
|
| [24] |
Xiao J, TuJ, Zhang H, et al. Risk factors of poor prognosis in patients with pyrrolidine alkaloid-induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt[J]. Hepatol Int, 2021, 15(3): 720-729.
|
| [25] |
Lv Y, Fan D, Han G. Transjugular intrahepatic portosystemic shunt for portal hypertension: 30 years experience from China[J]. Liver Int, 2023, 43(1): 18-33.
|
| [26] |
Angeloni S, Merli M, Salvatori FM, et al. Polytetrafluoroethylene-covered stent grafts for TIPS procedure: 1-year patency and clinical results[J]. Am J Gastroenterol, 2004, 99(2): 280-285.
|
| [27] |
Triantafyllou T, Aggarwal P, Gupta E, et al. Polytetrafluoroethylene-Covered Stent Graft Versus Bare Stent in Transjugular Intrahepatic Portosystemic Shunt: Systematic Review and Meta-Analysis[J]. J Laparoendosc Adv Surg Tech A, 2018, 28(7): 867-879.
|
| [28] |
Bucsics T, Schoder M, DiermayrI M, et al. Transjugular intrahepatic portosystemic shunts(TIPS) for the prevention of variceal re-bleeding-A two decades experience[J]. PLoS One, 2018, 13(1): e0189414.
|
| [29] |
ZHAO L, WU Q, LI Q, et al. TIPSS plus extrahepatic collateral embolisation may decrease variceal rebleeding and post-TIPSS hepatic encephalopathy[J]. Gut, 2023.
|
| [30] |
YaoJ, Zuo L, An G, et al. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension[J]. J Gastrointestin Liver Dis, 2015, 24(3): 301-307.
|
| [31] |
Lee EW, Eghtesad B, Garcia-Tsao G, et al. AASLD Practice Guidance on the use of TIPS, variceal embolization, and retrograde transvenous obliteration in the management of variceal hemorrhage [J]. Hepatology(Baltimore, Md), 2024, 79(1): 224-250.
|